Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs

Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets.

0 min read
Written by
Yiannis Kiachopoulos
  • Categories
  • Causaly
  • News
Receive the latest newsletter directly to your inbox

About Causaly

About Index Ventures

More on Causaly